Fabio Romerio of the University of Maryland, Baltimore in the U.S. seeks to identify surface biomarkers of HIV latently infected cells by comparing membrane proteomes of latently infected and uninfected cells. Unique biomarkers allow selective killing of latently infected cells with specific ligands, or targeted delivery of chemotherapeutic agents.